Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MDR-reversing agents reported by Nikken Chemicals

Nov. 12, 1997

Spotlight on topoisomerase I inhibitors

Nov. 12, 1997

DepoCyt to be reviewed by FDA advisory committee this month

Nov. 11, 1997

NCI supports R&D on antiangiogenic agents at Telios

Nov. 10, 1997

New taxoids from RPR

Nov. 10, 1997

Gensia Sicor terminates collaboration with Atrix

Nov. 7, 1997

Korean researchers describe new ginseng saponins with antitumor activity

Nov. 7, 1997

Safety of nemorubicin (daily x 3 every 28 days) evaluated in phase I trial

Nov. 6, 1997

New camptothecin analogues synthesized at U of Michigan

Nov. 5, 1997

Bristol-Myers Squibb prepares protein farnesyltransferase inhibitors

Nov. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...